Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Paula Ragan
FOU | Founder | 54 | 01/07/14 |
Adam Mostafa
DFI | Director of Finance/CFO | 44 | 01/09/18 |
Mary DiBiase
COO | Chief Operating Officer | 63 | 01/01/17 |
Chief Tech/Sci/R&D Officer | - | 01/08/23 | |
Art Taveras
CTO | Chief Tech/Sci/R&D Officer | 60 | 02/11/20 |
Murray Stewart
BRD | Director/Board Member | 63 | 29/03/19 |
Brian Bowersox
PRN | Corporate Officer/Principal | - | - |
Mark Baldry
PRN | Corporate Officer/Principal | 60 | 26/11/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Michael Wyzga
CHM | Chairman | 69 | 01/07/18 |
David McGirr
BRD | Director/Board Member | 69 | 01/09/17 |
Paula Ragan
FOU | Founder | 54 | 01/07/14 |
Gary Bridger
BRD | Director/Board Member | 61 | 01/10/18 |
Alison Lawton
BRD | Director/Board Member | 62 | 05/10/20 |
Bill Aliski
BRD | Director/Board Member | 75 | 18/09/19 |
Director/Board Member | 62 | 14/10/21 | |
Murray Stewart
BRD | Director/Board Member | 63 | 29/03/19 |
R. Woods
BRD | Director/Board Member | 56 | 01/09/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 167 937 781 | 162 460 401 ( 96,74 %) | 0 | 96,74 % |
Coordinate società
X4 Pharmaceuticals, Inc.
61 North Beacon Street 4th floor
02134, Boston
+857 529 8300
http://www.x4pharma.com![Indirizzo Arsanis Inc](https://cdn.zonebourse.com/static/address/38702344.png)
Settore
Vendite per regione
Variaz. 1 gen. | Capi. | |
---|---|---|
+15,35% | 122 Mrd | |
+17,64% | 113 Mrd | |
+17,47% | 26,22 Mrd | |
-23,38% | 19,01 Mrd | |
-19,56% | 15,71 Mrd | |
-19,26% | 15,22 Mrd | |
-47,37% | 14,72 Mrd | |
+59,28% | 14,58 Mrd | |
+5,00% | 13,84 Mrd |